tirzepatide and iih Efficacy of Dual GIP/GLP‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study - Azzam - 2025 - Endocrinology, Diabetes & Metabolism Recurrent Idiopathic Intracranial Hypertension–Related Papilledema

The instability of a mixed disulfide between roGFP2 and PfGrx was also supported by unsuccessful attempts to force and stabilize a Grx(SSR) species in titration experiments with roGFP2 C151 (SH) and up to 80 M PfGrx C88S (S 2 ) (Fig

"Differentiating malignant melanoma from other lesions using dermoscopy"

Case reports in youths have noted exacerbation or new onset of tics and repetitive compulsive behaviors [41,42]

While the inherent pharmacokinetic properties of each GLP-1 receptor agonist largely determine elimination time, several patient-specific factors can influence how quickly or slowly these medications clear from the body